Author: United States. Congress. House. Committee on Government ReformPublisher:
ISBN:
Category :
Languages : en
Pages : 140
Book Description
Office of National Drug Control Policy Reauthorization Act of 2005
Author: United States. Congress. House. Committee on Government ReformPublisher:
ISBN:
Category :
Languages : en
Pages : 140
Book Description
Office of National Drug Control Policy Reauthorization Act of 2005, November 18, 2005, 109-1 House Report 109-315, Part 1
Author: Office of National Drug Control Policy Reauthorization Act of 2005, March 3, 2006, 109-2 House Report 109-315, Part 3
Author: Office of National Drug Control Policy Reauthorization Act of 2005, March 3, 2006, 109-2 House Report 109-315, Part 2
Author: H.R. 2829, the Office of National Drug Control Policy Reauthorization Act of 2005
Author: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human ResourcesPublisher:
ISBN:
Category : Political Science
Languages : en
Pages : 168
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Office of National Drug Control Policy Reauthorization Act of 2005
Author: United States. Congress. House. Committee on Government ReformPublisher:
ISBN:
Category :
Languages : en
Pages : 56
Book Description
Office of National Drug Control Policy Reauthorization Act of 2003
Author: United States. Congress. House. Committee on Government ReformPublisher:
ISBN:
Category :
Languages : en
Pages : 80
Book Description
Legislative and Executive Calendar
Author: United States. Congress. Senate. Committee on the JudiciaryPublisher:
ISBN:
Category :
Languages : en
Pages : 240
Book Description
Author: